These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1670953)

  • 1. Electrical stimulation of the substantia nigra and changes of 2-phenylethylamine synthesis in the rat striatum.
    Juorio AV; Paterson IA; Zhu MY; Matte G
    J Neurochem; 1991 Jan; 56(1):213-20. PubMed ID: 1670953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in levels of dopamine and tyramine in the rat caudate nucleus following alterations in impulse flow in the nigrostriatal pathway.
    Jones RS; Juorio AV; Boulton AA
    J Neurochem; 1983 Feb; 40(2):396-401. PubMed ID: 6130125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Action of beta-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission.
    Barroso N; Rodriguez M
    Eur J Pharmacol; 1996 Feb; 297(3):195-203. PubMed ID: 8666050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration of striatal tyramine and dopamine metabolism in diabetic rats and effect of insulin administration.
    Kwok RP; Juorio AV
    Neuroendocrinology; 1986; 43(5):590-6. PubMed ID: 3528901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesion-induced reductions in trace amine accumulation: dependence on MAO inhibitor pretreatment.
    Nguyen TV; Juorio AV; Greenshaw AJ
    Brain Res Bull; 1989 Feb; 22(2):197-200. PubMed ID: 2495844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of striatal beta-phenylethylamine following dopamine but not 5-HT denervation.
    Greenshaw AJ; Juorio AV; Nguyen TV
    Brain Res Bull; 1986 Oct; 17(4):477-84. PubMed ID: 3096499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of some neuroleptics and d-amphetamine on striatal 2-phenylethylamine in the mouse.
    Juorio AV; Greenshaw AJ; Zhu MY; Paterson IA
    Gen Pharmacol; 1991; 22(2):407-13. PubMed ID: 1676007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the brain of the rat: implications for the origin of DOPAC.
    Soares-da-Silva P; Garrett MC
    Neuropharmacology; 1990 Oct; 29(10):869-74. PubMed ID: 1979427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
    Vrana SL; Azzaro AJ; Vrana KE
    Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine.
    Uretsky NJ; Snodgrass SR; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Dec; 195(3):465-79. PubMed ID: 490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of electrical stimulation of the nigrostriatal pathway of the rat on dopamine metabolism.
    Korf J; Grasdijk L; Westerink BH
    J Neurochem; 1976 Mar; 26(3):579-84. PubMed ID: 1262880
    [No Abstract]   [Full Text] [Related]  

  • 15. Biphasic influence of a 8 alpha-amino ergoline, CU 32-085, on striatal dopamine synthesis and turnover in vivo in the rat.
    Enz A
    Life Sci; 1981 Nov; 29(21):2227-34. PubMed ID: 6119592
    [No Abstract]   [Full Text] [Related]  

  • 16. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase-B by (-)-deprenyl potentiates neuronal responses to dopamine agonists but does not inhibit dopamine catabolism in the rat striatum.
    Paterson IA; Juorio AV; Berry MD; Zhu MY
    J Pharmacol Exp Ther; 1991 Sep; 258(3):1019-26. PubMed ID: 1679846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of yohimbine on brain monoamines: an in vivo study.
    Brannan T; Martinez-Tica J; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):81-7. PubMed ID: 1716906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E; Hefti F; Wurtman RJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylalanine in the caudate nucleus of dopamine depleted rats.
    Paetsch PR; Greenshaw AJ; Juorio AV
    Neurochem Res; 1993 Sep; 18(9):983-7. PubMed ID: 7694165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.